Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of MDM2-p53 Inhibitor APG-115 in Combination with Immunotherapy for the Treatment of Patients with Advanced Liposarcoma or other Advanced Solid Tumors in China 2020-10-27 08:13
CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1) 2020-10-27 07:23
Reistone Biopharma Announces Positive Topline Results from Phase 2 Clinical Trial Evaluating SHR0302, a JAK1 Inhibitor for the Treatment of Moderate-to-Severe Atopic Dermatitis 2020-10-26 19:40
Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus 2020-10-26 16:35
RhoVac Participates in BIO Europe Digital 2020-10-26 16:26
PharmAbcine to participate at BIO-Europe 2020 2020-10-23 20:00
TUV Rheinland Announces the Opening of its NABL Accredited Biomaterial and EMC Testing Laboratories 2020-10-23 09:15
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities 2020-10-22 21:00
Connect Biopharma to Present Additional Positive Results from the Phase 1b Study of CBP-201 for Patients with Moderate-to-Severe Atopic Dermatitis (AD) at EADV Virtual Meeting 2020-10-22 19:30
Longevity Acquisition Corporation Announces Signing of Definitive Merger Agreement 2020-10-22 14:00
Samsung Biologics' strategic business operations continue to support strong third quarter earnings 2020-10-21 19:00
Priority Review Granted to Ascentage Pharma's New Drug Application for Olverembatinib (HQP1351), the First Third-Generation BCR-ABL Inhibitor in China 2020-10-21 17:37
Cyclica to use Excelra's GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification 2020-10-21 10:00
Nanoform initiates GMP campaign for first-in-human trial of nanoformed drug by year end - ahead of schedule 2020-10-21 02:14
Samsung Biologics inks development partnership with Dinona for potential COVID-19 treatment 2020-10-20 19:00
Key patent granted for Isla101 in Brazil 2020-10-20 03:15
Samsung Biologics partners with BioEleven for cancer immunotherapy development and manufacturing 2020-10-19 19:00
Volition Veterinary Diagnostics Development LLC Announces Product Data Regarding its Nu.Q™ Vet Cancer Screening Test in Lymphoma and Hemangiosarcoma to be Presented at the 2020 VCS Virtual Annual Conference 2020-10-16 20:00
analytica 2020 - free entry from the computer 2020-10-16 17:29
Kazia Executes Agreement To Commence GBM Agile Pivotal Study 2020-10-16 07:30
1 273 274 275 276 277 451